Summit Creek Advisors LLC purchased a new stake in shares of Novanta Inc. (NASDAQ:NOVT – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 46,467 shares of the technology company’s stock, valued at approximately $7,099,000.
Several other hedge funds have also bought and sold shares of the stock. Vanguard Group Inc. grew its holdings in Novanta by 1.5% during the fourth quarter. Vanguard Group Inc. now owns 4,123,828 shares of the technology company’s stock valued at $629,997,000 after purchasing an additional 62,585 shares during the period. LPL Financial LLC boosted its stake in shares of Novanta by 19.6% in the fourth quarter. LPL Financial LLC now owns 21,537 shares of the technology company’s stock worth $3,246,000 after acquiring an additional 3,528 shares during the period. KLP Kapitalforvaltning AS bought a new position in shares of Novanta in the fourth quarter worth about $1,130,000. Sei Investments Co. boosted its stake in shares of Novanta by 2.2% in the fourth quarter. Sei Investments Co. now owns 255,641 shares of the technology company’s stock worth $39,054,000 after acquiring an additional 5,407 shares during the period. Finally, Quantbot Technologies LP bought a new position in shares of Novanta in the fourth quarter worth about $2,184,000. Institutional investors own 98.35% of the company’s stock.
Novanta Stock Performance
NASDAQ NOVT opened at $133.52 on Monday. The firm has a market cap of $4.80 billion, a price-to-earnings ratio of 79.95 and a beta of 1.34. The company has a quick ratio of 1.81, a current ratio of 2.79 and a debt-to-equity ratio of 0.61. The business has a 50-day moving average price of $144.31 and a 200-day moving average price of $159.75. Novanta Inc. has a twelve month low of $131.03 and a twelve month high of $187.12.
Analyst Ratings Changes
Separately, Robert W. Baird dropped their price objective on Novanta from $169.00 to $160.00 and set a “neutral” rating for the company in a research note on Monday, March 3rd.
Check Out Our Latest Stock Analysis on NOVT
About Novanta
Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.
Featured Stories
- Five stocks we like better than Novanta
- How to trade using analyst ratings
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- 3 ETFs to Ride the VIX Surge During Market Volatility
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Want to see what other hedge funds are holding NOVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Novanta Inc. (NASDAQ:NOVT – Free Report).
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.